Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas H Neufeld

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
BMJ Global Health|November 22, 2019
Stuck in the middle: a systematic review of authorship in collaborative health research in Africa, 2014-2016Bethany L Hedt-Gauthier, Herve Momo Jeufack, Nicholas H Neufeld, et al.
Neuropsychologia|September 29, 2012
Reading without the left ventral occipito-temporal cortexMohamed L Seghier, Nicholas H Neufeld, Peter Zeidman, et al.
Psychological Medicine|March 26, 2021
Association between psychomotor disturbance and treatment outcome in psychotic depression: a STOP-PD II reportAlastair J Flint, Kathleen S Bingham, Nicholas H Neufeld, et al.
Psychiatry Research|May 27, 2022
Factor analysis of the CORE measure of psychomotor disturbance in psychotic depression: Findings from the STOP-PD II studyKathleen S Bingham, Nicholas H Neufeld, George S Alexopoulos, et al.
Journal of Psychiatric Research|December 19, 2022
Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trialAlastair J Flint, Kathleen S Bingham, George S Alexopoulos, et al.
Molecular Psychiatry|March 20, 2024
Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic featuresHelena K Kim, Aristotle N Voineskos, Nicholas H Neufeld, et al.
Journal of Clinical Psychopharmacology|August 17, 2022
Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-AnalysisArgyrios Perivolaris, Nicholas J Ainsworth, George S Alexopoulos, et al.
Journal of Affective Disorders|May 23, 2026
Effect of continuation treatment on health-related quality of life in remitted psychotic depressionRyma A Bendel, George S Alexopoulos, Patricia Marino, et al.
Psychiatry Research|September 19, 2024
Predictors of attrition during acute pharmacotherapy of psychotic depression in a clinical trialRyma A Ihaddadene, George S Alexopoulos, Patricia Marino, et al.
JAMA Psychiatry|February 27, 2020
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical TrialAristotle N Voineskos, Benoit H Mulsant, Erin W Dickie, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
BMJ Global Health|November 22, 2019
Stuck in the middle: a systematic review of authorship in collaborative health research in Africa, 2014-2016Bethany L Hedt-Gauthier, Herve Momo Jeufack, Nicholas H Neufeld, et al.
Neuropsychologia|September 29, 2012
Reading without the left ventral occipito-temporal cortexMohamed L Seghier, Nicholas H Neufeld, Peter Zeidman, et al.
Psychological Medicine|March 26, 2021
Association between psychomotor disturbance and treatment outcome in psychotic depression: a STOP-PD II reportAlastair J Flint, Kathleen S Bingham, Nicholas H Neufeld, et al.
Psychiatry Research|May 27, 2022
Factor analysis of the CORE measure of psychomotor disturbance in psychotic depression: Findings from the STOP-PD II studyKathleen S Bingham, Nicholas H Neufeld, George S Alexopoulos, et al.
Journal of Psychiatric Research|December 19, 2022
Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trialAlastair J Flint, Kathleen S Bingham, George S Alexopoulos, et al.
Molecular Psychiatry|March 20, 2024
Effect of olanzapine exposure on relapse and brain structure in patients with major depressive disorder with psychotic featuresHelena K Kim, Aristotle N Voineskos, Nicholas H Neufeld, et al.
Journal of Clinical Psychopharmacology|August 17, 2022
Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-AnalysisArgyrios Perivolaris, Nicholas J Ainsworth, George S Alexopoulos, et al.
Journal of Affective Disorders|May 23, 2026
Effect of continuation treatment on health-related quality of life in remitted psychotic depressionRyma A Bendel, George S Alexopoulos, Patricia Marino, et al.
Psychiatry Research|September 19, 2024
Predictors of attrition during acute pharmacotherapy of psychotic depression in a clinical trialRyma A Ihaddadene, George S Alexopoulos, Patricia Marino, et al.
JAMA Psychiatry|February 27, 2020
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical TrialAristotle N Voineskos, Benoit H Mulsant, Erin W Dickie, et al.
Pageof 3